Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
about
Glycotherapy: new advances inspire a reemergence of glycans in medicineSynthesis of Bioinspired Carbohydrate Amphiphiles that Promote and Inhibit BiofilmsMultivalent glycoconjugates as anti-pathogenic agentsEnhanced amphiphilic profile of a short β-stranded peptide improves its antimicrobial activity.In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.Polymeric drugs: Advances in the development of pharmacologically active polymers.Dual action antimicrobials: nitric oxide release from quaternary ammonium-functionalized silica nanoparticles.Amino-terminated generation 2 poly(amidoamine) dendrimer as a potential broad-spectrum, nonresistance-inducing antibacterial agent.Targeting the bacteria-host interface: strategies in anti-adhesion therapy.Efficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factor-α and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM-1 cell line.Nitric oxide-releasing amphiphilic poly(amidoamine) (PAMAM) dendrimers as antibacterial agents.Bioconjugation on cube-octameric silsesquioxanes.Cyclodextrin-based multivalent glycodisplays: covalent and supramolecular conjugates to assess carbohydrate-protein interactions.Nanotechnology approaches for ocular drug delivery.A Nonbactericidal Zinc-Complexing Ligand as a Biofilm Inhibitor: Structure-Guided Contrasting Effects on Staphylococcus aureus Biofilm.Interactions of dendrimers with biological drug targets: reality or mystery - a gap in drug delivery and development research.Inhibition of type 1 fimbriae-mediated Escherichia coli adhesion and biofilm formation by trimeric cluster thiomannosides conjugated to diamond nanoparticles.Myeloid C-Type Lectin Receptors in Viral Recognition and Antiviral Immunity.Synthetic glycopeptides and glycoproteins with applications in biological research.Multivalent dendritic molecules as broad spectrum bacteria agglutination agents.Chemical space guided discovery of antimicrobial bridged bicyclic peptides against Pseudomonas aeruginosa and its biofilms.Electrochemiluminescent (ECL) [Ru(bpy)3](2+)/PAMAM dendrimer reactions: coreactant effect and 5-fluorouracil/dendrimer complex formation.Dendritic poly-chelator frameworks for multimeric bioconjugation.Combining topology and sequence design for the discovery of potent antimicrobial peptide dendrimers against multidrug-resistant Pseudomonas aeruginosa.Database of protein complexes with multivalent binding ability: Bival-Bind.Dendrimer mediated clustering of bacteria: improved aggregation and evaluation of bacterial response and viability.Temperature-Responsiveness and Antimicrobial Properties of CNT-PNIPAM Hybrid Brush FilmsPeptide dendrimers as "lead compounds" for the treatment of chronic lung infections by in cystic fibrosis patients: in vitro and in vivo studiesApplication of Dendrimers for the Treatment of Infectious Diseases
P2860
Q27027997-89D85483-0402-4576-AEFF-8A42C3876388Q35078648-27EC30B1-AB35-447F-BB3C-4C5D1D2135A2Q35444698-B0B01C09-0782-48F1-94F6-597BFBA76B36Q35548618-591CB0ED-BA14-4633-A062-CACE6E0F3133Q36290577-B689CB0A-2C1E-4035-B0B3-C30F3C083066Q36307604-3ED9990B-43A4-486F-9F4F-50D780E8190CQ36352429-D4B890FC-3B6F-4608-B47F-DF7BA4EC9B15Q36502394-2FD117F1-A238-4D87-88D0-63BD5A19ACE3Q37009022-6ADC8EF6-FDDC-4F49-8A39-A8C9AA7337B0Q37225620-456F76D1-31CC-4497-B249-2345561B67E5Q37274077-F2F40DC8-35C0-4185-8988-433D309BBFC3Q38072854-31BC267B-FC86-43D4-9A6F-5D9934E989AAQ38076027-CFF21D6B-7582-4613-B9E8-BE4F9F599A7BQ38098509-48E5D73F-A693-4F55-9E2B-48577F1EA1EDQ38691158-6B0C45E3-0574-40C6-8494-12F72C092F64Q38813936-AAA897F5-034F-4ECB-B596-98F6D457D600Q38923171-B8870189-9702-44A0-BB63-B90313597B08Q39192653-4F7B76C5-075B-43D4-AC2F-F12EDBE966C1Q41983543-742B6D53-D1C6-4A8C-8AD0-9A0AEAFE3104Q42631561-D3C2CF6A-EA56-4DA5-B69D-4C39FD629A26Q44157129-38E6C9C0-63C0-4E7E-B51C-AE514185C9B1Q46502513-297CEB04-C5BB-4D1E-ABA7-5DB6CC015746Q48248853-6451AD02-1426-434C-9B11-62FE219B5C6BQ51039965-44B77213-6B8F-4EDB-BA35-D70658B93A74Q52881713-501A5FF4-9963-47AF-B305-A8316D181FCFQ54503500-1F74D42F-5995-4E8D-B179-86ECCAA3E516Q57342984-A69E15C5-40A7-4BB8-8BF6-9F9BF015107EQ57815884-B3C28C19-9C1B-45FD-835A-601B1D6E6C1EQ58696083-508C4DED-35AB-4BF6-BEC0-D3ED209FF560
P2860
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@ast
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@en
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@nl
type
label
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@ast
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@en
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@nl
prefLabel
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@ast
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@en
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@nl
P2093
P2860
P356
P1476
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
@en
P2093
Eric L. Dane
George A. O’Toole
Mark W. Grinstaff
Meredith A. Mintzer
P2860
P304
P356
10.1021/MP2005033
P407
P577
2012-03-05T00:00:00Z